Loss of Integrin-linked kinase sensitizes breast cancer to SRC inhibitors. Beetham H, Griffith BGC, Murina O, Loftus AE, et al. Cancer Res 2021 Dec 17. pii: 0008-5472.CAN-21-0373.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Beetham H, Griffith BGC, Murina O, Loftus AE, et al. Loss of Integrin-linked kinase sensitizes breast cancer to SRC inhibitors. Cancer Res 2021 Dec 17. pii: 0008-5472.CAN-21-0373.
PMID: 34921014